GlassScriptPhysician profile
David John Roife
NPI 1326397761
$12,539.35
in general payments reported to CMS, 2019-2025
27 companies · $705 in 2025
The $705 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.32 · 2021: $32.81 · 2022: $9,982 · 2023: $161 · 2024: $1,622 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,662 · Travel and Lodging: $817 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,662.03 |
| Travel and Lodging | $816.70 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,206.41 | 2022-2024 | Da Vinci Surgical System |
| Smith+Nephew, INC. | $222.39 | 2024-2025 | Stravix, Grafix Pl, Oasis |
| Integra Lifesciences Corporation | $162.90 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medtronic, INC. | $141.94 | 2021-2025 | Emprint, Dextile |
| Lemaitre Vascular, INC. | $92.98 | 2025 | Artegraft Vascular Graft |
| Merck Sharp & Dohme LLC | $74.94 | 2022-2025 | Keytruda, Lynparza |
| Davol INC. | $64.23 | 2024-2025 | Phasix Mesh |
| Angiodynamics, INC. | $62.18 | 2023-2025 | Nanoknife |
| Polynovo North America LLC | $59.84 | 2024 | Novosorb Btm |
| Takeda Pharmaceuticals U.S.A., INC. | $50.22 | 2022-2023 | Gattex |
| Dilon Technologies, INC. | $46.30 | 2025 | Hemoblast Bellows |
| Sanara Medtech INC. | $43.27 | 2024-2025 | Celleraterx, Celleraterx |
| Histosonics, INC. | $34.68 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $26.74 | 2025 | |
| Medtronic USA, INC. | $26.06 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $25.57 | 2025 | Exparel |
| Kowa Pharmaceuticals America, INC. | $24.06 | 2022 | |
| Acera Surgical, INC. | $22.79 | 2025 | Restrata Wound Matrix |
| Ambu INC. | $22.68 | 2022 | |
| Aroa Biosurgery Incorporated | $19.46 | 2025 | |
| Kerecis Limited | $18.63 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Boston Scientific Corporation | $18.13 | 2021 | |
| Distalmotion US | $17.61 | 2025 | Dexter L6 Robot |
| Daiichi Sankyo INC. | $16.79 | 2022 | |
| Lexington Medical, INC. | $13.77 | 2025 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Mimedx Group, INC. | $13.52 | 2024 | |
| Fresenius Kabi USA, LLC | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Roife listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.